Stay updated on Biomarker-Directed Therapy in mCRC Clinical Trial

Sign up to get notified when there's something new on the Biomarker-Directed Therapy in mCRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker-Directed Therapy in mCRC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.5%
    Check dated 2025-05-29T05:55:13.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-30T13:58:20.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page has been updated to include new drug names related to colorectal cancer treatment, specifically Atezolizumab, Vemurafenib, Bevacizumab, Trastuzumab, Pertuzumab, Cobimetinib, 5-FU/LV, and Capecitabine, while significant details about a clinical trial have been removed.
    Difference
    23%
    Check dated 2025-04-16T02:50:35.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T00:38:50.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T19:04:42.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.5%
    Check dated 2025-03-03T22:28:50.000Z thumbnail image

Stay in the know with updates to Biomarker-Directed Therapy in mCRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker-Directed Therapy in mCRC Clinical Trial page.